Clinical Trials in Minneapolis

Showing 5161-5180 of 14,456 trials

Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)

NCT02829606

A device has been developed that has eye trackers integrated within the Head Mounted Display (HMD) and can remap text and images around the scotoma in real time to prevent information loss from a central scotoma. It can also carry out other types of image processing such as contrast enhancement and image magnification. The aim of this study is to assess the efficacy of this device on the visual performance of participants suffering from central vision loss, with and without remapping

Age-related Macular Degeneration

University of Minnesota8 participantsStarted Apr 2016

Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"

NCT04458181

The main objective of this study is to pilot test the Positive Peer Journaling (PPJ) \[later renamed "Positive Recovery Journaling" (PRJ)\] intervention and its feasibility and acceptability. A second objective is to compare individuals assigned to PPJ to individuals in a treatment as usual control group.

Addiction

University of Minnesota81 participantsStarted Jul 2020

Minneapolis, Minnesota, United States

TERMINATEDPhase 1< 1 mile

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

NCT02876640

This phase 1b trial studies the biologic effect of 9cUAB30 on early stage breast cancer. 9cUAB30 is a retinoid X receptor (RXR)-selective retinoid that acts in a tissue selective manner with the goal of minimizing side effects, a necessary feature of agents under development for cancer prevention.

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+6 more

National Cancer Institute (NCI)27 participantsStarted Mar 2018

Birmingham, Alabama, United States • Chicago, Illinois, United States • Iowa City, Iowa, United States +2 more locations

Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)

Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Find Trials by Condition in Minneapolis

Open-Label Study of Oral Treprostinil in Digital Ulcers

Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families

Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

A Study of Replagal in Treatment-naïve Adults With Fabry Disease